Fertility Tourism Market Global Report 2026

The fertility tourism market size has grown exponentially in recent years. It will grow from $0.96 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 29.9%. The growth in the historic period can be attributed to rising infertility rates globally, increasing awareness of assisted reproductive technologies, legalization of ivf and surrogacy in multiple countries, growth of medical tourism infrastructure, advancement in fertility clinic capabilities.

The fertility tourism market size is expected to see exponential growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 29.5%. The growth in the forecast period can be attributed to expansion of cross-border reproductive care networks, increasing affordability of assisted reproductive treatments, growing acceptance of non-traditional family structures, regulatory harmonization across fertility tourism destinations, integration of digital fertility consultation platforms. Major trends in the forecast period include rising adoption of cross-border fertility platforms integrating digital consultation and remote diagnostics, increasing demand for personalized IVF protocols using ai-driven embryo selection and reproductive analytics, growth of international surrogacy and donor matching networks enabling global patient mobility, expansion of fertility financing solutions including installment-based ivf and insurance-linked reproductive coverage, rising preference for specialized fertility clinics in destination countries offering advanced art technologies.

Growing health insurance coverage is expected to propel the growth of the fertility tourism market going forward. Health insurance refers to a financial protection system that assists individuals in paying for medical expenses, including diagnosis, treatment, hospitalization, and specialized healthcare services. The expansion in health insurance coverage is driven by rising healthcare costs, as increasing expenses related to medical consultations, treatments, hospital stays, and specialized procedures encourage individuals to obtain insurance coverage to reduce out-of-pocket healthcare spending. Health insurance supports fertility tourism by helping patients manage the financial burden of fertility treatments through partial reimbursement, international treatment coverage, or access to more affordable assisted reproductive services abroad. For instance, in September 2025, according to the Census Bureau, a US-based government statistical agency, private health insurance coverage recorded a 0.7% increase between 2023 and 2024, primarily supported by the growing adoption of direct-purchase insurance plans. Therefore, the growing health insurance coverage is driving the growth of the fertility tourism market.

Major companies operating in the fertility tourism market are focusing on integrating advanced genetic screening and personalized medicine solutions, such as embryo genetic optimization software integrated with whole-genome analysis and polygenic risk scoring systems, to enable IVF patients and clinicians to compare multiple embryos based on predicted disease risk profiles and individualized genetic outcomes before implantation. Embryo genetic optimization software is a computational system used in assisted reproduction that analyzes embryo genetic and morphological data to rank or prioritize embryos with the highest predicted viability and lowest risk of genetic abnormalities for selection. For instance, in June 2025, Nucleus Genomics, a US-based genomics company, launched Nucleus Embryo, a genetic optimization software platform for IVF embryo selection. The platform enables analysis of embryos across 900+ genetic conditions, incorporates polygenic risk scoring to estimate disease susceptibility, and provides embryo comparison tools that rank embryos based on predicted health outcomes and genetic traits.

In July 2023, BPEA EQT, a Hong Kong-based private equity investor focused on healthcare and consumer sectors, acquired a 60% majority stake in Indira IVF for $600 million, valuing the company at around $1.1 billion. The strategic objective of this acquisition was to accelerate Indira IVF’s expansion across India’s tier II and tier III cities while enhancing clinical capacity, digital infrastructure, and standardized fertility treatment protocols to support scale-driven growth in assisted reproductive services. Indira IVF is an India-based provider of IVF and assisted reproductive technology (ART) services operating a large multi-clinic fertility network across domestic and cross-border patient segments.

Major companies operating in the fertility tourism market are Monash IVF Group Limited; The Prelude Network LLC; GENNET; Create Fertility; Bourn Hall; Fertility First; Instituto Bernabeu S.L.; Clínica Tambre S.A.; Barcelona IVF S.L.; Dunya IVF Center Ltd.; Newlife IVF Greece S.A.; EmbryoClinic Assisted Reproduction Unit S.A.; Kiran Infertility Centre Private Limited; IVF Cube S.r.l.; Unica IVF Clinic s.r.o.; MMC IVF SDN. BHD.; Thomson Fertility Centre Pte. Ltd.; MOM Fertility Clinic S.A.; World Fertility Services LLC; Extraordinary Conceptions LLC.

Europe was the largest region in the fertility tourism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fertility tourism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fertility tourism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fertility tourism market includes revenues earned by entities by providing services such as hormonal fertility assessment, embryo transfer support, donor matching and counseling, fertility treatment planning, medical visa and documentation assistance, multilingual patient support, accommodation and travel arrangements, post-treatment follow-up care, and reproductive wellness counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The fertility tourism market research report is one of a series of new reports that provides fertility tourism market statistics, including fertility tourism industry global market size, regional shares, competitors with a fertility tourism market share, detailed fertility tourism market segments, market trends and opportunities, and any further data you may need to thrive in the fertility tourism industry. This fertility tourism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.